Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with ifosfamide in paediatric tumours.

J de Kraker1, P A Voûte

  • 1Werkgroep Kindertumoren, Emma Kinderziekenhuis, Amsterdam, The Netherlands.

Cancer Chemotherapy and Pharmacology
|January 1, 1989
PubMed
Summary

Ifosfamide chemotherapy shows high efficacy in childhood cancers, particularly soft-tissue sarcomas, achieving 78% survival. Early indicators of kidney toxicity include amino acid changes in urine and blood.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustainability assessment as problem structuring: three typical ways.

Sustainability science·2018
Same author

Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).

European journal of cancer (Oxford, England : 1990)·2015
Same author

Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study.

British journal of cancer·2014
Same author

Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.

European journal of cancer (Oxford, England : 1990)·2013
Same author

Incidence and outcomes of patients with late recurrence of Wilms' tumor.

Pediatric blood & cancer·2013
Same author

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

British journal of cancer·2008

Area of Science:

  • Pediatric Oncology
  • Pharmacology
  • Nephrology

Background:

  • Ifosfamide is a key chemotherapeutic agent for various pediatric malignancies.
  • Soft-tissue sarcomas exhibit notable sensitivity to ifosfamide treatment.

Purpose of the Study:

  • To evaluate the efficacy of ifosfamide in treating childhood tumors.
  • To identify early markers of ifosfamide-induced renal toxicity.

Main Methods:

  • Clinical data analysis of pediatric patients treated with ifosfamide.
  • Monitoring of urinary and plasma amino acid levels.

Main Results:

  • Actuarial survival rate of 78% observed in soft-tissue sarcoma patients.
  • Hyperaminoaciduria and transient hypaminoacidemia are early indicators of tubular damage.

Conclusions:

  • Ifosfamide is effective in treating childhood cancers, especially soft-tissue sarcomas.
  • Monitoring aminoaciduria is crucial for detecting early renal toxicity from ifosfamide.

Related Experiment Videos